Ledger.Open graph →
SEC Form D · filed March 7, 2022

Aperiam Bio, Inc

Offering
—
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUSTIN, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Austin Cole · Austin, TXExec · DirectorMatthew Bradley · Indianapolis, INExec · DirectorPeter O'Leary · DUBLIN, IrelandExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗